EDITOR'S NOTE
THE DRUG INFORMATION Association wishes to express its appreciation to Dr Charles C. Leighton for his participation in the DIA workshop on Clinical Data Management, September 1985.
Dr Leighton is a past president of the DIA. His keynote address to that workshop provides us not only with several challengeswhich hopefully we can respond to -but also with a brief history of the DIA and Clinical Data Management in the Pharmaceutical Industry. He also mentions the role of the DIA as a " . . . catalyst in bringing technical experts together for fruitful interchange of ideas, accomplishments and plans."
As Dr Roger Croswell, President of the DIA mentioned recently in his newsletter to the membership, "I feel our Association is assuming an ever-increasing role of importance in the drug development process, a role which has served to bring industry and FDA together for discussions on topics of varying disciplines and interests, but all concerned with the end result of helping to bring new and important therapies to the United States", we will also strive to satisfy that goal.
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